Harvard Bioscience
HBIO
#10463
Rank
A$39.18 M
Marketcap
A$8.69
Share price
-1.14%
Change (1 day)
1,204.04%
Change (1 year)

Earnings for Harvard Bioscience (HBIO)

Earnings in 2026 (TTM): -A$14.71 Million

According to Harvard Bioscience's latest financial reports the company's current earnings are A$85.53 Million. In 2025 the company made an earning of -A$82.28 Million a decrease over its 2024 earnings that were of -A$16.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harvard Bioscience from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$14.71 Million-82.13%
2025 -A$82.28 Million391.95%
2024 -A$16.73 Million356.38%
2023 -A$3.67 Million-72.15%
2022 -A$13.16 Million6456.43%
2021 -A$0.21 Million-98.08%
2020 -A$10.46 Million32.53%
2019 -A$7.89 Million-31.01%
2018 -A$11.44 Million243.9%
2017 -A$3.33 Million-24.66%
2016 -A$4.42 Million-14.69%
2015 -A$5.18 Million-181.68%
2014 A$6.33 M-9.97%
2013 A$7.03 M120%
2012 A$3.19 M-50.9%
2011 A$6.51 M-52.51%
2010 A$13.71 M-2.53%
2009 A$14.06 M28.26%
2008 A$10.96 M-20.05%
2007 A$13.71 M13.96%
2006 A$12.03 M17.59%
2005 A$10.23 M57.37%
2004 A$6.5 M-37.31%
2003 A$10.37 M208.03%
2002 A$3.36 M-168.71%
2001 -A$4.91 Million-66.89%
2000 -A$14.81 Million